These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 22628248

  • 1. A peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa.
    Mori N, Ishii Y, Tateda K, Kimura S, Kouyama Y, Inoko H, Mitsunaga S, Yamaguchi K, Yoshihara E.
    J Antimicrob Chemother; 2012 Sep; 67(9):2173-81. PubMed ID: 22628248
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antibacterial efficacy of inhaled squalamine in a rat model of chronic Pseudomonas aeruginosa pneumonia.
    Hraiech S, Brégeon F, Brunel JM, Rolain JM, Lepidi H, Andrieu V, Raoult D, Papazian L, Roch A.
    J Antimicrob Chemother; 2012 Oct; 67(10):2452-8. PubMed ID: 22744759
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 7. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE, Wang J, Nguyen VT, Turnidge JD, Li J, Nation RL.
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [Abstract] [Full Text] [Related]

  • 8. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G, Yang L, Wu H, Song Z, Wang H, Høiby N, Ulrich M, Molin S, Riethmüller J, Döring G.
    J Infect Dis; 2010 Nov 15; 202(10):1585-92. PubMed ID: 20942647
    [Abstract] [Full Text] [Related]

  • 9. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT, Tessier PR, Li C, Nightingale CH, Nicolau DP.
    Diagn Microbiol Infect Dis; 2007 Feb 15; 57(2):153-61. PubMed ID: 16930925
    [Abstract] [Full Text] [Related]

  • 10. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.
    Srinivas N, Jetter P, Ueberbacher BJ, Werneburg M, Zerbe K, Steinmann J, Van der Meijden B, Bernardini F, Lederer A, Dias RL, Misson PE, Henze H, Zumbrunn J, Gombert FO, Obrecht D, Hunziker P, Schauer S, Ziegler U, Käch A, Eberl L, Riedel K, DeMarco SJ, Robinson JA.
    Science; 2010 Feb 19; 327(5968):1010-3. PubMed ID: 20167788
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
    Maciá MD, Borrell N, Segura M, Gómez C, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2006 Mar 19; 50(3):975-83. PubMed ID: 16495260
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D, Muller A, Blanc K, Plésiat P, Talon D, Monnet DL, Bertrand X.
    Antimicrob Agents Chemother; 2008 Mar 19; 52(3):1173-5. PubMed ID: 18180356
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Güzel C, Gerçeker AA.
    J Antibiot (Tokyo); 2012 Feb 19; 65(2):83-6. PubMed ID: 22126897
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O, Ghiselli R, Silvestri C, Kamysz W, Orlando F, Mocchegiani F, Di Matteo F, Riva A, Lukasiak J, Scalise G, Saba V, Giacometti A.
    Antimicrob Agents Chemother; 2007 Jun 19; 51(6):2005-10. PubMed ID: 17403995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.